A nectin/nectin-like family protein, PVR, was recently identified as a binding partner for KIR2DL5 (23, 24), but the physiological role of the KIR2DL5/PVR pathway in tumor immunity and the therapeutic potential targeting this newly identified pathway have yet to be fully elucidated. This evidence concerns the gene PVR and neoplasm.